SCHEMBL3134474

SCHEMBL3134474

CC1(C)CCC(c2ccc(OCC3CO3)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
TP53 P04637 3/20 0.51
TSHR P16473 3/20 0.51
MAPT P10636 3/20 0.51
PPARG P37231 3/20 0.51
HPGD P15428 2/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
HIF1A Q16665 2/20 0.51
CYP1A2 P05177 1/20 0.51
TDP1 Q9NUW8 1/20 0.50
PKM P14618 2/20 0.48
LMNA P02545 2/20 0.48
GAA P10253 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.45
CYP3A4 P08684 1/20 0.45
GLA P06280 1/20 0.40
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2717675 0.86 TDP1 (0.61) ALDH1A1TP53TSHRMAPTPPARG
SCHEMBL3144279 0.83 TDP1 (0.58) ALDH1A1TP53TSHRMAPTPPARG
SCHEMBL22013527 0.82 ALDH1A1 (0.54) ALDH1A1TP53TSHRMAPTPPARG
SCHEMBL3135906 0.81 TDP1 (0.56) ALDH1A1TP53TSHRMAPTPPARG
SCHEMBL3133801 0.81 TDP1 (0.56) ALDH1A1TP53TSHRMAPTPPARG
SCHEMBL1008668 0.81 TDP1 (0.56) ALDH1A1TP53TSHRMAPTPPARG
SCHEMBL3143601 0.80 TDP1 (0.54) ALDH1A1TP53TSHRMAPTPPARG
SCHEMBL10179933 0.80 TDP1 (0.54) ALDH1A1TP53TSHRMAPTPPARG
SCHEMBL3138214 0.79 TSHR (0.33) ALDH1A1TP53TSHRMAPTPPARG
SCHEMBL23071545 0.79 ALDH1A1 (0.51) ALDH1A1TP53TSHRMAPTPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137193-B1 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF SANOFI SA (FR) 2017-08-09 EP disclosed
US-8642603-B2 Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof SANOFI (FR) 2014-02-04 US disclosed
US-20100075994-A1 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF SANOFI-AVENTIS (FR) 2010-03-25 US disclosed
EP-2137193-A2 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF Sanofi-Aventis (FR) 2009-12-30 EP disclosed
WO-2008112483-A2 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF SANOFI-AVENTIS (FR) 2008-09-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075994-A1 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF GRM2, GRM1, GRIN2C ALDH1A1 1875/4885TP53 4885/4885TSHR 513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.